Dr. Eric E. Bouhassira joined the Albert Einstein College of Medicine in 1990. He began studying human embryonic stem cells in 2001. He is director of the medical school's Center for Human Embryonic Stem Cell Research and professor of medicine and of cell biology. Dr. Bouhassira's research focuses on developing hematopoietic (blood forming) stem cells that can differentiate into red blood cells, T cells, platelets, and all other cell types that comprise blood. This work could potentially aid patients needing transfusions and also save lives by expanding the immunology diversity of hematopoietic stem cells available for transplant. Dr. Bouhassira is also interested in epigentic regulation in the erythoid and hematopoeitic lineag with a focus on DNA replication and DNA methylation. Dr. Bouhassira received his B.S., M.S., and Ph.D. degrees from the Université Pierre et Marie Curie in Paris, France. Dr. Bouhassira also holds the Ingeborg and Ira Rennert Chair in Stem Cell Biology and Regenerative Medicine.
Current Clinical Protocols
More Information About Dr. Eric Bouhassira
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Ullmann Building, Room 903A
Bronx, NY 10461
UPI features research by Drs. Mary E. Fabry and Eric E. Bouhassira which identifies a potential new treatment for thalassemia, a debilitating type of inherited anemia that affects millions of people worldwide.
Modern Healthcare interviews Drs. Eric Bouhassira and Jeffrey Pessin in a cover story on federal and state stem cell funding. The cover, entitled, Dishing it Out, appears in the March 16th edition.